Leadership

John P. Howe, III, M.D., President and CEO of Project HOPE

John P. Howe, III, M.D., became President and CEO of Project HOPE in 2001.

Before coming to Project HOPE, Dr. Howe was the Distinguished Chair in Health Policy at The University of Texas Health Science Center at San Antonio and served as the Center's chief executive for fifteen years. Dr. Howe is board certified in both internal medicine and cardiovascular disease.

Dr. Howe has a bachelor’s degree from Amherst College and earned his medical degree from Boston University School of Medicine. He served two years in the Army Medical Corps and later completed the Health Systems Management Program at Harvard Business School.

Board of Directors

Officers

Richard T. Clark ~  Chairman
Retired Chairman
Merck & Co., Inc.

George B. Abercrombie ~ Vice Chairman
Retired President & CEO
Hoffmann-LaRoche

William F. Brandt, Jr. ~ Treasurer
Retired Chairman & CEO
American Woodmark

Dayton Ogden ~ Secretary
Former Chairman
SpencerStuart Worldwide

Directors

John D. Fowler
Vice Chairman
Wells Fargo Securities

John W. Galiardo
Retired Vice Chairman
Becton, Dickinson and Company

Julie Gerberding, M.D.
President, Merck Vaccines
Merck & Co., Inc.

Jack M. Gill Ph.D.
President
The Gill Foundation

Bernard A. Harris, Jr., M.D.
President & CEO
Vesalius Ventures, Inc.

John P. Howe, III, M.D.
President & CEO
Project HOPE

Edward J. Ludwig
Retired Chairman
Becton Dickinson and Company

Dennis J. Manning
Retired Chairman & CEO
Guardian Life

Gerhard N. Mayr
Chairman
UCB

J. Michael McQuade, Ph.D.
Senior Vice President
Science & Technology
United Technology Corporation

Viren Mehta, Pharm.D
Mehta Partners LLC

Walter G. Montgomery
Partner & CEO
Robinson Lerer & Montgomery

Phebe Novakovic
President & Chief Operating Officer
General Dynamics

Steven B. Pfeiffer, Esq.
Chair of the Executive Committee
Fulbright & Jaworski LLP

Admiral Gary Roughead
Retired Chief of Naval Operations
United States Navy

Stephen H. Rusckowski
President and CEO 
Quest Diagnostics

Charles A. Sanders, M.D. ~ Chairman Emeritus
Retired Chairman & CEO
GlaxoSmithKline

Curt M. Selquist
Operating Partner
Water Street Healthcare Partners

Marshall Smith
Managing Director
Goldman Sachs & Company

Louis W. Sullivan, M.D.
President Emeritus
Morehouse School of Medicine

Henri A. Termeer
Former Chairman, President & CEO
Genzyme Corporation

Christian Weinrank
Vice President & Managing Director, Germany
Medtronic

Karen Welke
Retired Group Vice President
3M Company

Peter Wilden, Ph.D.
Chief Financial Officer
Ferring Pharmaceuticals

Bradley A. J. Wilson
Chairman
PharmaKodex Ltd.